Your browser doesn't support javascript.
loading
Chronic chikungunya disease (CCD): clinical insights, immunopathogenesis and therapeutic perspectives.
Ng, W H; Amaral, K; Javelle, E; Mahalingam, S.
Affiliation
  • Ng WH; Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia.
  • Amaral K; Global Virus Network (GVN) Centre of Excellence in Arboviruses, Griffith University, Gold Coast, QLD, Australia.
  • Javelle E; School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, Australia.
  • Mahalingam S; Department of Health Sciences, Federal University of Cariri, Barbalha, Ceará, Brazil.
QJM ; 117(7): 489-494, 2024 Jul 01.
Article in En | MEDLINE | ID: mdl-38377410
ABSTRACT
Chikungunya virus, an arthropod-borne pathogen is recognized by the World Health Organization as a top priority Emerging Infectious Disease and is ranked fourth in public health needs according to the Coalition for Epidemic Preparedness Innovations. Despite its substantial impact, as evidenced by an annual estimate of 120 274 disability-adjusted life years, our understanding of the chronic aspects of chikungunya disease remains limited. This review focuses on chronic chikungunya disease, emphasizing its clinical manifestations, immunopathogenesis, therapeutic options and disease burden.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chikungunya virus / Chikungunya Fever Limits: Humans Language: En Journal: QJM Journal subject: MEDICINA Year: 2024 Type: Article Affiliation country: Australia
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chikungunya virus / Chikungunya Fever Limits: Humans Language: En Journal: QJM Journal subject: MEDICINA Year: 2024 Type: Article Affiliation country: Australia